Document Detail

A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial.
MedLine Citation:
PMID:  22894624     Owner:  NLM     Status:  In-Data-Review    
ω-3 fatty acids reduce triglyceride (TG) levels, but corresponding increases in low-density lipoprotein cholesterol (LDL-C) levels may compromise achievement of lipid goals in patients with elevated cardiovascular risk. AMR101 is an investigational agent containing ≥96% of pure icosapent ethyl (the ethyl ester of eicosapentaenoic acid). The Phase III Multi-Center, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study with an Open-Label Extension (MARINE) investigated the efficacy and safety of AMR101 in 229 patients with very high TG levels (≥500 mg/dl). AMR101 4 g/day significantly reduced median placebo-adjusted TG levels from baseline by 33.1% (p < 0.0001), and AMR101 2 g/day reduced TG levels by 19.7% (p = 0.0051). Changes in LDL-C were minimal and nonsignificant. AMR101 may offer substantial TG lowering without increases in LDL-C levels.
Terry A Jacobson
Related Documents :
15886694 - Stable isotope probing - linking microbial identity to function.
8863794 - Understanding the mechanism of sweet taste: synthesis of ultrapotent guanidinoacetic ac...
14128044 - Localization of cytoplasmic nucleic acid during growth and encystment of entamoeba inva...
22486894 - The effect of using an alternative irrigant between sodium hypochlorite and chlorhexidi...
9630824 - The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with va...
2425004 - Therapy with a synthetic retinoid--(ro 10-1670) etretin--increases the cellular retinoi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  10     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-08-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  687-95     Citation Subset:  IM    
Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University, Atlanta, GA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  General Entry to Asymmetric One-Pot [N+2+n] Cyclization for the Synthesis of 3- to 7-Membered Azacyc...
Next Document:  Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial...